Compare Hims and Hers Health Inc (HIMS) vs iShares International Treasury Bond ETF (IGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs iShares International Treasury Bond ETF — how do they compare? Hims and Hers Health Inc trades at $29.32 (market cap $6.55B), while iShares International Treasury Bond ETF trades at $39.75 (market cap $1.30B). The key difference: Hims and Hers Health Inc is far larger — about 5× iShares International Treasury Bond ETF's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, iShares International Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and iShares International Treasury Bond ETF for 92 Days on average.
| HIMS | IGOV | |
|---|---|---|
Market Cap | $6.55B | $1.30B |
Volume | 14,842,814 | 693,740 |
Sector | Health | Fixed Income |
52-Week High | $62.76 | $42.99 |
52-Week Low | $14.52 | $39.65 |
Typical Hold Time | 21 Days | 92 Days |
Enterprise Value | $7.25B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.
The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.
IGOV trades at $39.75 with minimal daily movement (+0.13%). Technical indicators show a bearish bias with moving averages signaling caution, though oscillators remain neutral. The stock faces significant resistance at $40 across multiple levels. Financial ratios are unavailable in current data, limiting fundamental assessment.
The stock's outlook remains cautious due to technical weakness and limited fundamental visibility. Rising bond yields create macroeconomic headwinds for equities, though inverse Treasury ETFs may benefit. Investors require updated financial disclosures to properly evaluate valuation and growth prospects amid current market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →
